From July 1, 2023 to September 30, 2023, the company has repurchased 4,148,600 shares, representing 0.55% for CNY 29.56 million. With this, the company has completed the repurchase of 14,148,600 shares, representing 1.84% for CNY 100.02 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.56 CNY | +1.23% | +6.67% | -4.93% |
1st Jan change | Capi. | |
---|---|---|
-4.93% | 640M | |
+20.76% | 43.18B | |
+20.23% | 22.59B | |
+15.11% | 14.56B | |
+42.30% | 11.5B | |
-8.51% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- 600351 Stock
- News Yabao Pharmaceutical Group Co., Ltd
- Tranche Update on Yabao Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on May 9, 2023.